A Phase 1b, Randomized, Double-Blind, Placebo Controlled, Single-Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-5806 in Subjects < 24 Months of Age [...] (2014–2015)
- Grant type:
- Gilead Pty Ltd
- Researchers:
-
-
- Funded by:
- Gilead Sciences Pty Limited
